Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ciprofloxacin
United Therapeutics Europe Ltd
Acute Lymphoblastic Leukaemia - Category
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
ClearSight HPI Monitoring system
Grace Therapeutics
Anesthesia, Epidural
1 trial -
Clostridium butyricum (live) Tablets(Meiya)
Rocket Pharmaceuticals B.V.
Rectal Cancer
1 trial -
CocoaVia supplement
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Colostrum supplementation for bone loss
Petros Pharmaceuticals
Osteopenia
1 trial -
Combination Product: Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Combination of chemotherapy and immunotherapy
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Control lidocaine cream
The First People's Hospital of Lianyungang
Atopic Dermatitis
1 trial -
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial -
Conventional Artificial Cycle Therapy
Jian Li
Infertility, Female
1 trial -
Conventional second-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Cyclosporin A
The First People's Hospital of Lianyungang
Acute Leukemia
1 trial -
D-Galactose
United Therapeutics Europe Ltd
Focal Segmental Glomerulosclerosis
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Dairy based toddler nutrition
United Therapeutics Europe Ltd
Weight Gain
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources